Association of COVID-19 Quarantine Duration and Postquarantine Transmission Risk in 4 University Cohorts.


Journal

JAMA network open
ISSN: 2574-3805
Titre abrégé: JAMA Netw Open
Pays: United States
ID NLM: 101729235

Informations de publication

Date de publication:
01 02 2022
Historique:
entrez: 25 2 2022
pubmed: 26 2 2022
medline: 8 3 2022
Statut: epublish

Résumé

Optimal quarantine length for COVID-19 infection is unclear, in part owing to limited empirical data. To assess postquarantine transmission risk for various quarantine lengths and potential associations between quarantine strictness and transmission risk. Retrospective cohort study in 4 US universities from September 2020 to February 2021, including 3641 university students and staff who were identified as close contacts to individuals who tested positive for SARS-CoV-2 infection. Individuals were tested throughout the 10 to 14-day quarantine, and follow-up testing continued at least weekly throughout the 2020-2021 academic year. Strict quarantine, including designated housing with a private room, private bathroom, and meal delivery, vs nonstrict, which potentially included interactions with household members. Dates of last known exposure, last negative test result, and first positive test result during quarantine. This study included 301 quarantined university students and staff who tested SARS-CoV-2-positive (of 3641 quarantined total). These 301 individuals had a median (IQR) age of 22.0 (20.0-25.0) years; 131 (43.5%) identified as female; and 20 (6.6%) were staff. Of the 287 self-reporting race and ethnicity according to university-defined classifications, 21 (7.3%) were African American or Black, 60 (20.9%) Asian, 17 (5.9%) Hispanic or Latinx, 174 (60.6%) White, and 15 (5.2%) other (including multiracial and/or multiethnic). Of the 301 participants, 40 (13.3%; 95% CI, 9.9%-17.6%) had negative test results and were asymptomatic on day 7 compared with 15 (4.9%; 95% CI, 3.0%-8.1%) and 4 (1.4%; 95% CI, 0.4%-3.5%) on days 10 and 14, respectively. Individuals in strict quarantine tested positive less frequently than those in nonstrict quarantine (10% vs 12%; P = .04). To maintain the 5% transmission risk used as the basis for US Centers for Disease Control and Prevention's 7-day test-based quarantine guidance, our data suggest that quarantine with quantitative polymerase chain reaction testing 1 day before intended release should be 10 days for nonstrict quarantine and 8 days for strict quarantine, as ongoing exposure during quarantine may be associated with the higher rate of positive test results following nonstrict quarantine.

Identifiants

pubmed: 35212750
pii: 2789427
doi: 10.1001/jamanetworkopen.2022.0088
pmc: PMC8881770
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e220088

Subventions

Organisme : NIGMS NIH HHS
ID : R01 GM120122
Pays : United States
Organisme : NHGRI NIH HHS
ID : T32 HG002295
Pays : United States

Commentaires et corrections

Type : CommentIn

Références

MMWR Morb Mortal Wkly Rep. 2020 Nov 20;69(46):1743-1747
pubmed: 33211678
JAMA Netw Open. 2021 Jan 4;4(1):e2035057
pubmed: 33410879
Nat Commun. 2021 Jan 7;12(1):356
pubmed: 33414470
BMC Med. 2021 Apr 14;19(1):94
pubmed: 33849546
BMC Med. 2021 Apr 27;19(1):106
pubmed: 33902581
Ann Intern Med. 2020 May 5;172(9):577-582
pubmed: 32150748
Ann Intern Med. 2020 Aug 18;173(4):262-267
pubmed: 32422057
Nat Med. 2020 May;26(5):672-675
pubmed: 32296168
MMWR Morb Mortal Wkly Rep. 2021 Jan 01;69(5152):1633-1637
pubmed: 33382676
JAMA. 2021 Apr 20;325(15):1561-1562
pubmed: 33605978

Auteurs

Andrew Bo Liu (AB)

Bioinformatics and Integrative Genomics PhD Program, Harvard Medical School, Boston, Massachusetts.

Dan Davidi (D)

Department of Genetics, Harvard Medical School, Boston, Massachusetts.

Hannah Emily Landsberg (HE)

Student Health Services, Boston University, Boston, Massachusetts.

Maria Francesconi (M)

Harvard University Health Services, Boston, Massachusetts.

Judy T Platt (JT)

Student Health Services, Boston University, Boston, Massachusetts.

Giang T Nguyen (GT)

Harvard University Health Services, Boston, Massachusetts.
Department of Medicine, Harvard Medical School, Boston, Massachusetts.

Sehyo Yune (S)

Student Affairs Northeastern University, Boston, Massachusetts.

Anastasia Deckard (A)

Office of Information Technology, Duke University, Durham, North Carolina.

Jamie Puglin (J)

Office of Assessment, Duke University, Durham, North Carolina.

Steven B Haase (SB)

Department of Medicine, Duke University School of Medicine, Durham, North Carolina.

Davidson H Hamer (DH)

Department of Global Health, Boston University School of Public Health, Boston, Massachusetts.
Section of Infectious Diseases, Department of Medicine, Boston University School of Medicine, Boston, Massachusetts.
National Emerging Infectious Diseases Laboratory, Boston University, Boston, Massachusetts.

Michael Springer (M)

Department of Systems Biology, Harvard Medical School, Boston, Massachusetts.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH